ulcerative

Eisai: Announcement About an Approval for Additional Indication of Jyseleca, JAK inhibitor

ruth 29 March

3 minutes

TOKYO, Mar 28, 2022 – (JCN Newswire via SEAPRWire.com) – Gilead Sciences K.K., Eisai Co., Ltd. and EA Pharma Co., Ltd. announced that Gilead acquired an approval of additional indication […]

JCN Newswire

Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies

ruth 23 April

4 minutes

TOKYO, Apr 23, 2021 – (JCN Newswire via SEAPRWire.com) – Gilead Sciences K.K. and Eisai Co., Ltd. today announced that Gilead submitted an application to Japan’s Pharmaceuticals and Medical Devices […]